Suven Life Sciences Announcements
Significant movement in price has been observed in Suven Life Sciences Limited. The Exchange, in order to ensure that investors have latest relevant information about...
08 Apr, 2026 | 11:06am • Source: NSE
The Exchange has sought clarification from Suven Life Sciences Ltd on April 7, 2026 with reference to significant movement in price, in order to ensure...
07 Apr, 2026 | 08:01pm • Source: BSE
Certificate under Reg 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 31st March, 2026
06 Apr, 2026 | 03:49pm • Source: BSE
ALLOTMENT OF 3,17,68,764 EQUITY SHARES OF THE COMPANY ON PREFERENTIAL BASIS
06 Mar, 2026 | 11:45am • Source: BSE
Allotment of Securities
06 Mar, 2026 | 11:37am • Source: BSE
Special window for Re-lodgment of transfer requests of physical securities
19 Feb, 2026 | 01:04pm • Source: BSE
Monitoring Agency Report for the quarter ended December 31, 2025
03 Feb, 2026 | 02:27pm • Source: BSE
Newspaper advt. - Unaudited financial results for the quarter and nine months ended 31st December, 2025
30 Jan, 2026 | 03:46pm • Source: BSE
Appointment of Ms. Sangeetha Laxmi Kandari (ICSI M. No. A40736) as Company Secretary & Compliance Officer (KMP) of the Company
29 Jan, 2026 | 01:33pm • Source: BSE
Resignation of Mr. Shrenik Soni, Company Secretary & Compliance Officer (KMP) of the Company
29 Jan, 2026 | 01:26pm • Source: BSE
Allotment of 44,77,612 of Equity Shares of the Company on preferential basis upon conversion 44,77,612 fully paid warrants
29 Jan, 2026 | 01:23pm • Source: BSE
Outcome of the Board Meeting
29 Jan, 2026 | 01:17pm • Source: BSE
Suven Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/01/2026 ,inter alia, to consider...
22 Jan, 2026 | 02:50pm • Source: BSE
Certificate under Reg.74(5) of SEBI (DP) Regulations
06 Jan, 2026 | 10:14am • Source: BSE
Please find enclosed News Release of our company
11 Dec, 2025 | 10:15am • Source: BSE